Concourse Financial Group Securities, Inc. Pmv Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
21 transactions
Others Institutions Holding PMVP
# of Institutions
63Shares Held
37.5MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA6.48MShares$8.48 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.29MShares$6.93 Million6.78% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$4.89 Million1.89% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.19MShares$4.18 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.44 Million0.92% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $59.8M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...